Cargando…

The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients

BACKGROUND: Despite its efficacy, FAC regimen may cause fatal cardiotoxicity. Carvedilol may also exert additional antioxidant effects. This study aimed to assess the effect of carvedilol in preventing decline of left ventricular function in breast cancer patients receiving FAC regimen chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wibawa Martha, Januar, Soedarsono, Dery A., Iqbal, Mohammad, Astuti, Astri, Martanto, Erwan, Rizki Akbar, Mohammad, Sumantra, I. Gede
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339049/ https://www.ncbi.nlm.nih.gov/pubmed/32671185 http://dx.doi.org/10.1016/j.ijcha.2020.100575

Ejemplares similares

Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis
por: Wibowo, Arief, et al.
Publicado: (2021)

Global and Regional Longitudinal Strain Reduction in Breast Cancer Patients After First Chemotherapy Cycle With Fluorouracil, Adriamycin, and Cyclophosphamide Regimen
por: Astuti, Astri, et al.
Publicado: (2021)

Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression
por: Wibowo, Arief, et al.
Publicado: (2021)

Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

The Prognostic Value of Hyponatremia for Predicting Poor Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Akbar, Mohammad Rizki, et al.
Publicado: (2021)

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin
por: Abuosa, Ahmed Mohamed, et al.
Publicado: (2018)

The prognostic value of elevated creatine kinase to predict poor outcome in patients with COVID-19 - A systematic review and meta-analysis
por: Akbar, Mohammad Rizki, et al.
Publicado: (2021)

Cardiotoxicity by Anthracycline Regimen Chemotherapy Prolonged T Peak to T End Interval
por: Iqbal, Mohammad, et al.
Publicado: (2020)

Endotheliopathy marked by high von Willebrand factor (vWF) antigen in COVID-19 is associated with poor outcome: a systematic review and meta-analysis
por: Wibowo, Arief, et al.
Publicado: (2022)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis
por: Prameswari, Hawani Sasmaya, et al.
Publicado: (2023)

Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

The Difference in Accuracy Between Global Registry of Acute Coronary Events Score and Thrombolysis in Myocardial Infarction Score in Predicting In-Hospital Mortality of Acute ST-Elevation Myocardial Infarction Patients
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Thenappan, Thenappan, et al.
Publicado: (2021)

PC-FACS
por: Arnold, Robert M.
Publicado: (2020)

PC-FACS
por: Arnold, Robert M.
Publicado: (2020)

Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia
por: Tual, L, et al.
Publicado: (2006)

Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

Hypertensive heart disease: Benefit of carvedilol in hemodynamic, left ventricular remodeling, and survival
por: Dominguez, Renata F, et al.
Publicado: (2019)

Carvedilol improves left ventricular diastolic dysfunction in patients with transfusion-dependent thalassemia
por: Silvilairat, Suchaya, et al.
Publicado: (2021)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
por: Lee, Myunhee, et al.
Publicado: (2021)

Non-Aqueous Electromigration Analysis of Some Degradation Products of Carvedilol
por: Jouyban, Abolghasem, et al.
Publicado: (2014)

PC-FACS: COVID-19
por: Arnold, Robert M.
Publicado: (2020)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Ovarian cancer: Pathogenesis and current recommendations for prophylactic surgery
por: Budiana, I Nyoman Gede, et al.
Publicado: (2019)

Gene expression profiles of Bapx1 expressing FACS sorted cells from wildtype and Bapx1-EGFP null mouse embryos
por: Chatterjee, Sumantra, et al.
Publicado: (2015)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia
por: Isa Tafreshi, Roya, et al.
Publicado: (2022)

Salvos fac nos : suite para órgano Op. 109
por: Casas, Felipe de las
Publicado: (1964)

The Effect of Enalapril and Carvedilol on Left Ventricular Dysfunction in Middle Childhood and Adolescent Patients With Muscular Dystrophy
por: Kwon, Hye Won, et al.
Publicado: (2012)

Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
por: Pölönen, R. P., et al.
Publicado: (2018)

Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure
por: Karabacak, Mustafa, et al.
Publicado: (2015)

Evaluation of the Effect of Carvedilol in Preventing Right Ventricular Dysfunction in Breast Cancer Patients Receiving Anthracycline
por: Karvandi, Mersede, et al.
Publicado: (2023)

Cardiologic Phenotypes and Natural History of FAC
por: Rapezzi, Claudio
Publicado: (2015)

Jeffrey L. Ponsky, MD, FACS
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_10ako4emcul8dl4ncb1ud3fvo5